NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

Yesterday's HTA inspection report ranks up there with the importance of the recent
Liau joining the SAB announcement. Bright Boy is correct; the stock should be $5 . The almost zero notations by the HTA inspectors suggests that Sawston is one of the best run cell based immunotherapy factories in the world. Probably all of the 16 checkpoint inhibitor manufacturers would like to own it. The disparity between $0.70 and $5.00 suggests that nwbo is a manipulated stock , as alleged by the NWBO-Cohen Millstein lawsuit.

What could change that ?

-MAA filed
-MAA final approval
-uplist to NYSE or NASDAQ
- big financing at $5.00 or above
-CLR partnership for North American manufacturing of DC VAX L
-combo partnerships to corroborate 50% of patients surviving 7-10 years, with 5-10% experiencing cure
- updated Liau combo results
-RA agnostioc tissue approvals
- Flaskworks approval for integration into the Sawston manufacturing process.
-lawsuit reveal; $ collected; MTD dismissed
-NICE reimbursement approval
- guidance on RA approval application submissions beyond the MHRA